ENDONOVO THERAPEUTICS, INC. Stock Issued During Period, Value, Employee Benefit Plan
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- ENDONOVO THERAPEUTICS, INC. stock issued during period, value, employee benefit plan for the quarter ending 2023-09-30 was $4.55K.
- ENDONOVO THERAPEUTICS, INC. stock issued during period, value, employee benefit plan for the quarter ending 2023-06-30 was $6.03K.
| Period end | Stock Issued During Period, Value, Employee Benefit Plan 3 month | Stock Issued During Period, Value, Employee Benefit Plan 12 month |
|---|---|---|
| 2023-09-30 | $4.55K 10-Q · filed 2023-12-29 | |
| 2023-06-30 | $6.03K 10-Q · filed 2023-12-29 |